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A previous communication (1) outlined the prophylactic effect in M. mulatta 
<ff formol-inactivated suspensions of mumps virus prepared from the infected 
parotid gland.  It was shown  that  the injection of such  material led, in the 
majority of animals, to the production of specific complement-fixing antibody. 
Moreover in about 60 per cent of the vaccinated animals evidence of increased 
resistance on challenge with active mumps virus was obtained. 
In view of the results in monkeys,  similar experiments were carried out in 
human  beings  employing  the  complement  fixation  test  and  the  skin  test, 
which have been  recently described  (2--4),  as means  of  selecting individuals 
presumptively susceptible to mumps.  The present report reviews these inves- 
tigations. 
Methods  and  Materials 
Procedures Employed in Selecting  Individuals and in Testing  the Effect of Vaccination.--With 
~:onsent of their parents or guardians, four groups of children were studied who were inmates of 
3 institutions.  Subsequently these groups will be referred to as 1, 2, 3, and 4.  In addition a 
number of adults and children who were naturally exposed to mumps within their families 
were vaccinated and their subsequent behavior observed.  The results so obtained will also 
be briefly summarized. 
A negative complement fixation test (3) was the only criterion of susceptibility in the 
selection of groups 1 and 2.  In choosing the individuals for group 3, not only were the results 
of this test used, but also as a further check on susceptibility,  skin tests (4) were carried out 
after the challenging  inoculation had been administered.  Group 4 consisted of those who, 
at the beginning of the experiment, were found to be negative both by complement fixation 
and skin test. 
* These investigations  have been carried out as a project of the Commission on Measles and 
Mumps, Army Epidemiological Board, Preventive Medicine Service, Office of the Surgeon 
Generali U. S. Army, Washington, D. C. 
We wish to express our great  appreciation  for the assistance of Mrs. Jeanette H. Levens and 
Miss Beatrice Payson without whose indispensable  contributions in carrying out the technical 
procedures these investigations could not have been completed. 
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The procedures were varied because of the following considerations.  It has been shown 
that certain persons may respond to  the skin test by the formation of complement-fixing 
antibody (4).  It is possible, therefore, that the skin test also might alone give rise to some 
increase in resistance.  In the first 2 experiments it seemed desirable to avoid such a response 
by omitting this test, although it was realized that by so doing a  few resistant individuals 
might be included, since not all persons previously infected with the virus indefinitely retain 
demonstrable antibody in their serum (2).  In the third experiment skin tests were done at 
the end of the period of incubation when it seemed that an immunizing effect would not 
occur as a  result of such tests.  The skin test, however, was used at the outset in the 4th 
experiment because at this point it appeared  to  be of greater importance to obtain every 
assurance possible  that only susceptible persons were  originally included  than it was  to 
eliminate any adjuvant immunizing effect of the skin test. 
In a few instances negative histories of mumps were also accepted as corroborative evidence 
of susceptibility.  But on the whole a  history of mumps in institutionalized children has 
often in our experience been unreliable, and so has usually been disregarded. 
In groups 1, 2, and 4  approximately half the children were given suspensions of mumps 
virus inactivated by the addition of formalin (1).  The others were  reserved  as controls. 
In group 3 about two-thirds of the children were vaccinated.  On the 14th to the 17th day 
after the first dose of vaccine was injected, the resistance of all the children in each group was 
challenged by the inoculation of active monkey virus.  A suspension of the virus was intro- 
duced directly into one Stensen's duct of each of the children in groups 1 and 2.  The material 
was sprayed over the surface of the buccal mucosa of those in groups 3 and 4. 
Preparation of Formolized Vaccine.--The  method of preparing the vaccine has been previ- 
ously described (1).  A 10 per cent suspension of the infected gland in physiologic salt solution 
containing 0.3 per cent commercial formalin was used in groups 1 and 2; a 2.5 per cent sus- 
pension containing the same  concentration of formalin was  employed in groups  3  and 4. 
The vaccines were kept in rubber-capped vials at about 4°C.  until injected.  In the first 
experiment the period of storage before use was 47 days, in the second 11 days, in the third 
60 days, and in the fourth 7 days. 
Dosage and Technique of Vaccination and Challenge.--Formolized vaccine was administered 
in groups i, 2, and 4 by the subcutaneous route in 2 doses each of 0.3 ml. of the 10 per cent 
or 0.5 ml. of the 2.5 per cent suspension at an interval of 5 days,  In group 3, 3 doses of 2.5 
per cent vaccine were given subcutaneously at intervals of 5 days. 
To afford the optimal practical method for the control of mumps in the field, a  vaccine 
should lead to the induction of immunity within the incubation period.  Since this period is 
approximately 15  to 21 days,  the time selected for challenging the vaccinated groups was 
14 to  17 days from the date of the first injection of vaccine.  It has been demonstrated 
previously in susceptible monkeys (1)  and, it will be shown in this communication that in 
susceptible human beings also  the mumps  experimentally produced  by injection of virus 
directly into Stensen's duct, is characterized by an incubation period of about 6 to 7 days. 
Thus in the cases of those vaccinated persons who were inoculated v/a the duct and sub- 
sequently developed the disease, the interval from the time of the first injection of vaccine 
to that of the appearance of fully developed mumps was about 19 to 22 days; i.e., the usual 
incubation period of the natural disease.  Accordingly these conditions of vaccination and of 
challenge inoculation, although they did not precisely reproduce those which might occur 
in  epidemics,  nevertheless seemed  reasonably exacting.  When  the  challenging virus  was 
sprayed, the incubation period which varied from 17 to 22 days was comparable to the range 
exhibited by the natural disease.  Here, then, the interval elapsing between the first injection 
of vaccine and the appearance of symptoms, when they occurred, was from 31 to 39 days.  In 
the group of adults and children who were naturally exposed,  the vaccine, of course, was 
administered after the exposure had occurred. STOKES~ ENDERS~ MARIS~ AND  KAN~  409 
The amount of active virus used for intraparotid  challenge was 0.4 ml. of a  5 per cent 
~uspension in infusion broth or physiologic salt solution of infected monkey parotid.  When 
the virus was sprayed, the inoculum consisted in group 3 of 0.75 ml. of a 4 per cent suspension 
of infected monkey gland, and in group 4 of 1 ml. of a 6 per cent suspension of gland.  The 
titer of complement-fixing antigen of the inocula used in groups 1 and 2 was between 1-300 
.and  1-500; that of the inoculum employed in group 3 was 1-375, in group 4 it was 1-1S0. 
Materials of the  10th,  llth,  12th,  13th,  and  14th monkey passages were employed.  The 
infective capacity of the virus was demonstrated in susceptible monkeys both immediately 
before and shortly after its inoculation into human beings.  Suspensions of active virus were 
kept frozen in solid CO~ until just before they were used. 
That the virus employed for challenge was similar in all essential respects to the agent 
responsible for the natural disease was shown by the behavior of a child exposed by chance 
to mumps which had developed in a boy who had previously received active monkey virus 
in  the form of a  spray.  This accidental  exposure to  the experimental disease gave rise, 
after the average period of incubation, to a typical attack of mumps. 
Clinical Criteria Employed in the Diagnosis of Experimental Mumps.---Increase  in tempera- 
ture,  enlargement of the parotid glands, enlargement of the other salivary glands, redness 
about Stensen's duct, and symptoms of discomfort, anorexia, headache, and nausea, when they 
occurred, were recorded daily by a  group of nurses in constant attendance  and who took 
care of no other patients.  The children were also visited daily by one or two of the authors 
who confirmed and likewise recorded the significant findings. 
Although all these signs and symptoms were noted, many were so irregular in occurrence 
and in intensity that in the analysis of the data we have depended mainly upon the enlarge- 
ment of the parotid glands as a criterion of clinically apparent disease.  In this communica- 
tion,  therefore,  the details only of parotid  swelling will be presented  and  merely general 
reference, when relevant, made to other possible manifestations of infection.  The degree of 
parotid swelling observed each day has been recorded by a simple system of arbitrary units: 
1 -- unmistakable but minimal enlargement 
2  --- moderate enlargement 
3 --- marked enlargement 
4, 5, 6,  =  increasing degrees of marked enlargement 
Complement Fixation  Tests.mBefore injection of the vaccine and  repeatedly  thereafter 
the serum of each child was tested for the presence of complement-fixing antibody.  The 
technique employed in such tests has been described (1). 
Skin Tests.--The preparation of the materials used for this test and the manner in which 
they are employed have been described in previous communications (2, 4). 
The El~ect of Vaccination  as Revealed by Clinical Observation 
Groups 1 and 2.--These two experiments in which active viru  s was introduced 
via the parotid duct were carried out essentially in the same manner.  The 
results,  therefore,  can be regarded as fairly comparable.  Group 1 consisted 
of 6 vaccinated and 6 control children; group 2 of 9 vaccinated  t and 8 controls. 
t One of the vaccinated subgroup in group 2, J. H., was not challenged by intraparotid in- 
oculation but received active virus in the form of a spray.  He is therefore not mentioned in 
Table LI but his immunologic responses are recorded in Table VI.  It is of interest that among 
a  number of children who were inadvertently exposed  to J. H., 6 cases of mumps occurred. 
The first of these came down 17 days after the onset of J. H.'s case and the others at various 
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In  group  2  were  also  included  3  unvaccinated  children  who  gave  serologic 
evidence of previous attacks of mumps as indicated by the presence of com- 
plement-fixing  antibody  in  their  sera  at  the  beginning  of  the  experiment. 
Presumably,  therefore,  these  individuals would  be  resistant  to  inoculation 
because of a  previously acquired natural immunity  (2, 3). 
TABLE I 
Group 1. Swelling of Inoculated Parotid Gland Following Introduction of A crime Virus via 
Stensen'  s Duct 
Subgroup  Name 
Accumulated units of swelling 
First 4 days  After 4th day 
Total*  Moderate  Moderate 
or markedt  Total  or marked 
Duration  Estimate 
i of swelling 
!  after  of resist- 
4th day  ance§ 
1 
Vaccinated 
Mean.. 
2 
Controls 
days 
E.N.  0  4  2  3  R 
C.Q.  5  8  7  4  R 
A.R.  2  7  4  4  R 
S.R.  6  3  2  2  R 
A.S.  2  8  4  6  R 
J.S.  0  17  14  7  S 
3.3  2.5  8  6  4.3 
W.B.  0  18  14  10  S 
P.D.  0  18  15  9  S 
L.K.  0  13  11  6  S 
P.M.  2  14  12  8  S 
N.  P.  0  17  13  10  S 
F.R.  2  16  13  9  S 
Mean .....  0.8  0.7  16  13  8.5 
* Figures indicate accumulated daily units of all swelling recorded as "i+"  or greater 
according to the notation described on p. 409. 
Figures indicate accumulated daily swelling of moderate or marked degree (see p. 409). 
§ R indicates that the individual presented evidence of increased resistance according to 
the criteria mentioned in the text; S indicates no evidence of increased resistance. 
Difference in Behavior of the Inoculated Parotid Gland Exhibited by Naturally 
Resistant and Susceptible Vaccinated and Unvaccinated Individuals.--A variable 
degree of swelling of the inoculated gland appeared Mter the challenge in all who 
received the virus by this route.  But the interval between the challenge and 
the  time  at  which  the maximal enlargement  of the  gland  was noted  varied 
considerably in  the vaccinated and  control  groups.  In Tables I  and  II the 
accumulated degree of all swelling as well as of mode.rate or marked enlargement 
of the inoculated gland recorded for each individual in groups 1 and 2 before STOKES,  ENDERS, MAR.IS,  AND  KANE  411 
and after the 4th  day is presented.  It is clear that many  of the vaccinated 
children  (subgroups  1)  exhibited considerable enlargement before the 4th day 
TABLE II 
Group 2.  Swdling of Inoculated Parotid Gland Following Introduction of Active Virus via 
Stensen'  s Duct 
Accumulated units of swelling 
Subgroup  Name  First 4 days  After 4th day 
Moderate  Moderate 
Total*  or marked~  Total  or marked 
1 
Vaccinated 
Duration  Estimate 
of swelling  after  of resist- 
4thday  ance§ 
days 
C.B.  0  0  2  0  2  R 
R.B.  4  2  8  8  5  S 
J.C.  8  6  1  0  1  R 
G.H.  2  2  9  5  6  S 
C.H.  11  11  3  2  3  R 
L.K.  2  2  3  0  4  R 
E.O.  9  9  7  4  6  R 
F.O.  12  12  0  0  0  R 
Mean..  6.0  5.5  4.1  2.3  3.3 
2 
Controls 
M.G.  5  2  11  I0  4  S 
W.L.  II  9  4  0  4  R 
L.M.  0  0  10  9  4  S 
M.N.  2  2  5  4  3  R 
C.N.  3  0  20  18  9  S 
G.P.  1  0  16  15  7  S 
R.V.  10  9  11  11  3  R 
Mean. 
3[[  G. diC. 
Positive comple-  W.H. 
ment fixation  G.L. 
Mean... 
4.5  3.1  11  9.5  4.8 
3  0  1  0  1  R 
3  2  0  0  0  R 
8  7  9  5  6  R 
4.6  3.0  3.3  1.6  2.3 
* See footnote  *, Table I. 
;~ See footnote  ~, Table I. 
§ See footnote  §, Table I. 
[[ The individuals  in this group were not vaccinated but had positive complement fixation 
tests at the beginning of the experiment. 
which tended to disappear relatively soon thereafter.  In contrast, the majority 
of those in the unvaccinated groups (subgroups 2)  showed little or no swelling 
before the 4th day.  That which appeared subsequently in most of the controls, 412  r~o~Xr~Ty IN  Mtrm,  s.  w 
as compared with the majority of vaccinated children, was more marked and of 
longer  duration.  These  differences  are  reflected in  the  differences between 
the means of the total swelling before and after the 4th day in the vaccinated 
and control groups.  It can be shown by a  "t-test" that  these means differ 
significanlty in the first experiment  (P  -  <0.01)  and are on the borderline 
of significance in the second experiment (P =  0.05).2 
There is experimental evidence which indicates that this accelerated response 
to  intraparotid  inoculation  of  the  virus  is  characteristic  of  the  Previously 
infected and consequently resistant organism.  As Johnson and Goodpasture 
(5) observed, and as we have repeatedly noted (1), the monkey convalescent 
from mumps, when  reinoculated,  frequently responds by an  enlargement  of 
the gland which occurs within 24 to 48 hours and thereafter gradually subsides. 
In the normal monkey, on the other hand, a definite increase in the size of the 
gland is not usually discernible before the 6th postinoculative day.  That the 
same phenomenon may occur in man is demonstrated by the results obtained 
in the 3 unvaccinated children with initially positive complement fixation tests 
who are mentioned in subgroup 3 of Table II.  It will be seen that these indi- 
viduals all responded to the challenge with active virus by accelerated enlarge- 
ment of the gland which in only one persisted longer than the 3rd day after 
inoculation.  These facts, then, would appear to warrant the conclusion that 
the  significantly higher  incidence  of accelerated  reactions in  the  vaccinated 
groups as contrasted  with  the controls indicated  in the former an  enhanced 
resistance. 
Although it is possible, as we have done, to compare numerically each group 
with  the  other,  it  is impossible, because  of the  small numbers  involved,  to 
obtain an exact quantitative value indicative of resistance or susceptibility in 
the case of any one child.  Nevertheless it would seem fair to assume that a 
child in whom a very large proportion of the total swelling occurred after the 
4th day was susceptible and conversely that a child who exhibited a relatively 
small proportion of swelling after this time was resistant or partially resistant. 
On  the  basis  of these  criteria,  we have indicated  in  Tables I  and  II those 
individuals  whom we  consider  to  have  been  susceptible  or  resistant  to  the 
challenge.  These estimates may be summarized as follows:-- 
Vaccinated  Controls 
Resistant  Susceptible  Resistant  Susceptible 
Group I ...........  5  1  0  6 
Group II  ..........  6  2  3  4 
Total .............  11  3  3  10 
2  The differences were taken as the total degree of swelling occurring before the 4th day 
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Apparently about four-fifths of  the vaccinated may be considered to have 
exhibited evidence of  resistance as  compared with  about  one-fourth of  the 
controls.  If  so,  it  may  be  concluded that  in about  one-half  the  children 
resistance was increased as a  result of vaccination. 
Extension of Infection to the Other SaUvary Glands.--Only one of all those included in both 
of these experiments developed swelling of the uninoculated parotid  gland.  On the other 
hand, some enlargement of the submaxillary and sublingual glands was recorded in many 
instances.  The degree of such enlargement on the whole was considerably greater  in the 
controls.  Although, as already stated, we are not inclined to stress the significance of such 
observations, in these cases the difference in swelling of these other salivary glands probably 
affords further evidence for the protective effectiveness of vaccination. 
Groups 3 and 4.--To avoid the development of an accelerated reaction which, 
when  it  tends  to  persist,  may render it difficult to  determine whether  true 
parotitis of the inoculated gland has subsequently ensued and also to secure 
more information concerning the value of the vaccine, two additional experi- 
ments were  carried out in which the  children were challenged by copiously 
spraying the oral cavity with active virus.  Following this procedure no defi- 
nite  accelerated  reactions  were  observed.  The  disease  which  ensued  after 
incubation periods ranging from 17 to 22 days closely resembled that encoun- 
tered in nature.  In some cases both parotids were enlarged, in others the paro- 
titis was unilateral.  The accumulated units of swelling of both glands recorded 
for each subject are presented in Tables III and IV. 
With the exception of the change in the route of challenge inoculation, the design of the 
experiments in general was the same as that formerly followed.  In group 3, however, the 
children who were to receive the vaccine were divided into 2 subgroups, one of which received 
2 doses and the other 3 doses.  This was done to determine whether an increase in the amount 
of vaccine, as well as repetition of antigenic stimulation, would prove more effective. 
To supplement the information obtained by means of complement fixation tests concerning 
the susceptibility of these children, it will be recalled that skin tests were also carried out at 
the time symptoms of mumps appeared in group 3 and at the beginning of the experiment in 
group 4.  In attempting to evaluate the data recorded in Table III, it should be borne in 
mind that positive skin tests were obtained in 4 of the children in group 3 (R. S. and C. C., 
subgroup 1; C. Bu., subgroup 2; T. McG., subgroup 3, see Table VII).  We have, therefore, 
excluded them from the discussion of the prophylactic effect of the vaccine which follows. 
In group 4, besides the vaccinated and control subgroups, several other children were included 
(subgroup  3,  Tables  IV and VIII).  They consisted of 4  unvaccinated  individuals who 
originaUy showed doubtful or negative skin and complement fixation tests  but who later 
developed appreciable antibody titers, presumably as a result of the skin tests  (4), and a 
fifth child who had a persistently negative complement fixation test but exhibited a dermal 
reaction at 24 hours which, however, faded at 48 hours (Table VIII).  These children were 
offered the challenge in an attempt to learn something in regard to the significance of these 
ambiguous immunologic responses in relation to resistance. 
Incidence  of  Parotitis  in  Vaccinated  and  Control  Groups.--We  may  first 
analyze the results obtained in group 3  (Table III).  It is clear that neither Subgroup 
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TABLE  IIl 
Group 3.  Swelling of Both Parotld  Glands Following Introdudion  of Actice Virus as an 
Oral Spray 
Name 
1 
Vaccinated twice 
Mean .... 
2 
Vaccinated three 
times 
Mean 
Controls 
Mean 
Accumulated units of swelling 
S.B. 
A.B. 
R.B. 
C.C. 
J.E. 
R.H. 
E.M. 
F.M. 
F.O. 
R.S. 
C. B1. 
Co Bu. 
R.C. 
C.H. 
E.R. 
R.S. 
M.S. 
J. We. 
C. Wh. 
J. Wi. 
R.B. 
R.F. 
T.F. 
L.J. 
C.K. 
T. McG. 
W.P. 
J.S. 
M.W. 
E.W. 
Duration of 
swelling  Moderate or 
Total*  marked:~ 
0  0 
2  0 
3  0 
0  0 
80  75 
0  0 
10  9 
2  0 
0  0 
0  0 
9.7  8.4 
4  2 
0  0 
34  33 
0  0 
0  0 
2  0 
9  6 
0  0 
2  0 
22  16 
7.3  5.7 
5  2 
0  0 
15  13 
6  0 
17  14 
0  0 
6  4 
I1  6 
20  15 
12  9 
9.2  6.3 
days 
0 
2 
2 
0 
12 
0 
4 
2 
0 
0 
2.2 
2 
0 
7 
0 
0 
1 
4 
0 
2 
7 
2.3 
2 
0 
4 
4 
5 
0 
4 
5 
5 
4 
3.3 
414 
Estimate of 
resistance§ 
R 
R 
R 
R 
S 
R 
S 
R 
R 
R 
S 
R 
S 
R 
R 
R 
S 
R 
R 
S 
S 
R 
S 
S 
S 
R 
S 
S 
S 
S 
* Figures indicate accumulated daily units of swelling of both parotid glands. 
$ Figures indicate accumulated daily units of swelling of both parotid  glands recorded as 
moderate or marked (see p. 409). 
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TABLE IV 
Group 4.  Swelling  of Both Parotid  Glands Following Introduction  of Aaive Virus as an 
Oral Spray 
Subgroup 
1 
Vaccinated 
Name 
J.B° 
W.B. 
J.C. 
J.F. 
A.K. 
E.M. 
J.N. 
J.R. 
G.T. 
A.Y. 
Accumulated units of swelling 
Duration  of 
swelling 
days 
1 
0 
0 
1 
6 
1 
0 
0" 
0 
0 
Mean ..........................  0.9 
2  R. Gre. 
R. Gri. 
E.J. 
T.J. 
R.K. 
E.L. 
J.P. 
W.P. 
L.P. 
M.W. 
Controls 
6 
5 
0 
6 
6 
0 
0 
0 
5 
4 
Total*  Moderate or 
marked~ 
2  0 
0  0 
O  0 
1  0 
15  14 
4?  4? 
0  0 
0  0 
0  0 
0  0 
2.2  1.8 
22  22 
15  15 
0  0 
8  0 
35  33 
0  0 
0  0 
0  0 
12  10 
13  12 
10.5  9.2  Mean ..........................  3.2 
311  A.G. 
Originalimmunologic  I M.M. 
status doubtful.  T.P. 
No vaccine  H.j.T.S. 
Mean ..........................  1.0 
0 
0 
4 
0 
0 
0.8 
Estimate of 
resistance§ 
R 
R 
R 
R 
S 
R 
R 
R 
R 
R 
S 
S 
R 
S 
S 
R 
R 
R 
S 
S 
R 
R 
S 
R 
R 
* See footnote *, Table III. 
See footnote ~, Table III. 
§ See footnote §, Table I. 
[1 See text and Table VIII for details concerning these individuals. 
the  means  of  total  accumulated  swelling  nor  the  average  duration  of  the 
parotitis  were significantly di~erent in the vaccinated and  control subgroups. 
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marked  involvement  of  the  gland.  Nevertheless,  an  examination  of  the 
individual results strongly suggests that the vaccine acted prophylactically in 
certain instances.  Thus, excluding the children in each subgroup who gave 
positive skin tests, it is apparent that all the controls exhibited a moderate or 
marked parotitis.  In  contrast,  in a  considerable number of the  vaccinated 
children the swelling was minimal or absent. 
To obtain  a  basis  for comparison, we have assumed  that any vaccinated 
individual showed evidence of increased resistance whose total accumulated 
parotid swelling was approximately one-half (or less) that of the control child 
(R. B) who revealed in his subgroup the least degree of enlargement  among 
those who presented any signs  of parotitis.  According  to this criterion, in 
Table III we have indicated the immunologic status of each child.  Omitting 
the individuals definitely positive by the first skin  test,  these estimates  for 
group 3 may be*summarized as follows:-- 
Vaccinated  Controls 
Resistant  Susceptible  Resistant  Susceptible 
11  6  1  8 
The difference between  the  vaccinated and  controls is still  apparent  if one 
considers only those children who did not react in any way to the first  skin 
test :- 
Vaccinated  Controls 
Resistant  Susceptible  Resistant  Susceptible 
7  3  0  5 
Further evidence in support of this criterion of resistance may be derived from 
a comparison of Tables III and VII which shows that none of the 7 vaccinated 
children considered to be resistant on the basis of total accumulated swelling 
exhibited sufficient enlargement of the glands to be recorded as  moderate or 
marked (2+ or greater).  Such responses, on the other hand, were noted in all 
the skin-test-negative controls.  As in groups I and 2, then, there is indication 
here that the vaccine enhanced the resistance in at least one-half of those to 
whom it was given and who were considered to be susceptible on the  basis of 
skin and complement fixation tests. 
The data, however, show that the prophylactic effect of the vaccine was not 
increased when 3 instead of 2 doses were administered.  Indeed less protection 
seems to have been induced by the greater quantity of antigen.  If not due to 
chance variation, this somewhat paradoxical result may possibly be attributable 
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inoculation was only 5 days in the case of the subgroup which received 3 doses 
as compared with 10 days in the subgroup which received 2 doses.  A period so 
short may not have been sufficient to permit the occurrence of maximal anti- 
genic stimulation, especially if any resistance  induced by the first 2 doses of 
vaccine were temporarily depressed by the third injection of inactivated virus. 
The fourth experiment yielded similar  results.  From Table IV,  it is ap- 
parent  that the  incidence  of parotid enlargement of any significant  degree 
among the vaccinated is less than in the control group.  Indeed only one of the 
10 vaccinated children developed  swelling comparable  to that shown by 6 of 
the controls.  As before we may tabulate the results as follows:-- 
Vaccinated  Controls 
Resistant  l  Susceptible  Resistant  Susceptible 
9  [  1  4  6 
The difference in the means of the total accumulated swelling, which is here 
statistically significant,  reflects the behavior of the individuals.  It is accord- 
ingly again possible to attribute a prophylactic effect to the vaccine in about 
one-half of those who received it. 
Compared with those in group 3, a relatively large proportion of the controls in this experi- 
ment in spite of preliminary negative skin and complement fixation tests proved resistant 
on challenge.  It is possible that in group 4, the inoculation of the skin test material, which 
itself has been shown to have some antigenic capacity (4), may have increased resistance by 
affording an additional stimulus which was not received by the children of group 3. 
Only 1 of the 5 unvaccinated children (subgroup 3, Table IV) who developed antibody as 
a  result of  skin-testing or presented doubtful  skin  reactions before challenge showed un- 
equivocal signs of mumps.  The results obtained in this group will be subsequently discussed 
when the immunologic data obtained in the 4 experiments are reviewed. 
Swdling of the Submaxillary and Sublingual Glands.--The  majority of children both among 
vaccinated and controls in groups 3 and 4 presented varying degrees of enlargement of  the 
submaxillary and sublingual glands.  But in many  instances some increase in  the size of 
these organs or in the tissues adjacent to them was recorded within a week after the challenge 
had been given; i.e., a week or 10 days before parotid involvement, when it occurred, was dis- 
cerned.  Accordingly considerable doubt existed in the minds of those who carried out the 
examinations as to whether in any given case such signs were to be attributed to infection with 
the virus of mumps or to other causes such as perhaps a  response to the introduction of an 
irritative or allergenic factor existing in the monkey gland emulsion.  That these reactions, in 
certain instances at least, may well have been of a non-specific character is supported by the 
fact that the children in group 3 whose skin tests were found to be positive and who failed to 
develop parotitis nevertheless did present enlargement of either the submaxillary or sublingual 
glands.  Since, as we have seen (2, 4), it is probable  that the majority of these children had 
been rendered immune by previous inapparent disease, in them at least it would seem reason- 
able to interpret the swelling of the~e glands as not indicative of primary viral infection.  The 
cause, therefore, of such swelling in any individual among the vaccinated and control children 
must remain in doubt in both of these experiments. 418  IMMUNITY IN MUMPS.  VI 
Results  of  Vaccination  Following  Natural  Exposure  to  Mumps 
As occasion offered, both adults and children who were exposed to cases of 
mumps which had occurred in nearly all  instances within their own families 
were given 2 injections of 2.5 per cent formolized vaccine at an interval of 5 
days.  In  all  these  cases  the  history  of mumps  was  negative  or  doubtful. 
Only those whose skin tests were considered to be negative or questionably 
negative, i.e., erythema less than 11 >( 11 ram. (average diameter) were selected 
for vaccination.  Whenever possible other members of the family who were 
similarly exposed and whose history and  skin  tests  were negative were not 
vaccinated,  and so served as controls. 
Of a total of 98 individuals, 50 gave negative or questionably negative skin 
tests.  Twenty-seven  of  these  negative  reactors  were  vaccinated.  Among 
them  10  cases  of mumps  subsequently appeared.  Five of the  23  negative 
reactors  who  did  not  receive the  vaccine developed mumps.  Three  other 
unvaccinated individuals who reacted to the skin test (13)< 13 mm. in 2 cases, 
23 )< 23 in 1 case) also came down with the disease. 
Although it was recognized that the intensity of exposure varied consider- 
ably, and although the number of those who became ill was small, these results 
appear to be unequivocal in showing that under the conditions described the 
vaccine when administered after infection does not prevent the development of 
parotitis.  This result is not surprising in view of many unsuccessful attempts 
to establish active immunity in viral diseases after infection has occurred. 
It cannot be, however, positively asserted that the vaccination was entirely 
without effect.  Inspection of the clinical data shows that 3 cases among the 
unvaccinated  were  characterized  by extensive involvement  of  the  salivary 
glands  with marked enlargement.  In none of the vaccinated persons were 
these signs more than moderately developed.  Moreover the disease in one of 
the unvaccinated cases was complicated by orchitis and in another by menin- 
goencephalitis.  These observations, then, suggest without being in any sense 
conclusive, that vaccination after exposure may tend to reduce the severity of 
the simple disease and prevent or diminish its complications. 
The Effects of Vaccination and Experimental Infection as Revealed by 
Immunologic Procedures 
An examination of the immunologic data summarized in Tables V, VI, VII, 
and VIII reveals several facts of interest. 
Negative Complement Fixation and Skin Tests as Indices of Susceptibility.- 
In  the  first place,  they show that  the sera of all  the experimental subjects 
selected for vaccination  contained no  detectable  antibody.  Its  absence  in 
most instances was confirmed by repeated tests on  specimens obtained just 
before the first or second dose of vaccine was administered.  Negative tests 
were also characteristic of the children selected as controls.  These facts, as STOKES~  ENDERS~  MARIS~  AND  KANE  419 
previously pointed out, afford reasonable assurance that presumably about two- 
thirds  at  least of  the  individuals  selected were susceptible  (3).  In  the  third 
TABLE V 
Group 1.  Results of Immunologic Tests 
Subgroup  " 
Received 2 
doses of 
vaccine 
2~ 
Received no 
racine 
Name 
E.N, 
C.Q. 
A.R. 
S.R. 
A.S. 
I.S. 
W.B 
P. D. 
L.K. 
P.M 
N.P. 
F.R. 
*o 
~.~ 
t/2 
0 
0 
0 
0 
0 
0 
0  0 
o  o 
0  0 
0  0 
0  0 
0  0 
o 
"~  ~  o 
O 
/26  ~  4/'7 
O§  0 
0  0 
0  0 
0  0 
0  0 
0  0 
od*~ 
nd 
nd 
nd 
nd 
nd 
Serial en~  ~lement fixation tests 
Prior tl 
:hallent 
1943" 
4/19 
24 
O? 
0 
384 
0 
6(w 
0 
o 
0 
0 
0 
0 
Following challenge 
1943  [944 
4/26  5/3  5/10  5/17 
6  192  [536  1536 
0  192  384  >384 
0  384  768  1536 
768  192  [536  1536 
0  192  384  1536 
6  192  192  >384 
0  0  96  1536 
0  192  384  1536 
0  24  96  384 
0  96  96  768 
0  0  384  1536 
0  24  I  192  1536 
;/22 
24 
24 
61 
.24 
24 
[92 
16 
48 
24 
16 
nd 
24 I 
Skin test 
1944 
?/26 
Sens.[I 
?¶ 
? sens. 
? sens. 
+ 
nd 
+ 
0 
+ 
nd 
nd 
+ 
* Blood samples for complement fixation tests were taken  a few minutes before vaccine 
or challenge materials were given. 
Subgroup  1 received subcutaneously on April 2 and Apri[ 7,  1943, respectively 0.5 ml. 
of a  10 per cent suspension of formolized infected parotid gland of the 9th monkey passage. 
On April 19,  1943, all the individuals in subgronps  1 and 2 were inoculated unilaterally in 
Stensen's duct with 0.4 ml. of active virus of the llth monkey passage diluted 1-15 in infusion 
broth. 
§ Titer of complement fixation test is recorded as the reciprocal of the highest final dilu' 
t/on of serum giving fixation denoted by "1+."  In certain instances where this endpoint 
was not actually observed, it was calculated as the geometrical mean of the dilutions which 
showed fixation greater than "1+" and less than "1 +" respectively. 
I] Sens. indicated that  the individual reacted  to the control material  containing normal 
monkey parotid. 
¶  ? indicates that either an erythematous reaction less than  10 X  10 ram. was observed 
at 48 hours or that a reaction occurred at 24 hours but disappeared by 48 hours. 
** nd, not done. 
series  of  experiments  the  results  of  skin  testing  were  used  after  challenge 
to increase  the  chances  of including  only susceptible  children.  On  the basis 
of  the  results  so  obtained,  4  individuals  in  these experiments  who  had been 420  ~iT,z  IN  u~m,s,  w 
originally chosen on the basis of negative complement fixation tests were re- 
vealed as presumptively resistant and so have been excluded from considera- 
TABLE  VI 
Croup 2.  Results of Immunologic Tests 
Serial complement fixation tests  Skin test 
• •  Prior tc  Following challenge  Orlgmal  h 1  Subgroup  Name  test  ,  c a-  1944 
1943"  lenge  1943  1944  1943" 
5/18  6/15  6/21  6/28  "1/5  7/13  7/25  7/25 
15  C.B.  0§  0  0  192  384  1536  96  + 
',eceived  2  R.B.  0  0  0  96  384  1536  48  ?[I 
doses of vac-  J.C.  0  96  384  384  384  1536  24  + 
cine  J.H.  0  0  6?  6?  96  768  48  + 
G.H.  0  0  0  96  192  768  48  +  sl.  sens.¶ 
C.H.  0  1536  >1536  1536  1536  1536  48  0 
L.K.  0  3072  >1536  1536  1536  1536  96  + 
E.O.  0  48  96  384  1536  1536  48  + 
F.O.  0  1536  >1536  1536  768  1536  192  Sens. 
2~  M.G.  0  rid**  0  96  192  1536  48  + 
Controls  re-  W.L.  0  nd  0  384  192  192  24  -k 
ceived no vac-  L.M.  0  nd  0  384  192  1536  48  + 
cine  M.N.  0  nd  0  96  192  384  48  ? 
C.N.  0  nd  0  96?  192  384  48  ? 
G.P.  0  nd  0  6?  192  384  12  + 
R.V.  0  nd  0  384  384  768  96  + 
3~  G.  >24  nd  24  384  384  1536  192  + 
]mmune  by  DiC.  i 
complement  W. H  >24  [ nd  96  48  192  192  48  + 
fixation test  G.L.  >24  nd  96  384  384  ac~l  24  0 
* Blood samples for complement fixation tests  were taken before vaccination was begun 
and a  few minutes before challenge material was given. 
:~ Subgroup 1 received subcutaneously on June i  and  June 6, 1943, 0.3 ml. of a pooled 10 
per cent formolized suspension of the infected parotid  glands of the 10th and 12th monkey 
passages.  On June 15, 1943, all the individuals (with the exception of J. H. who was sprayed) 
in subgroups 1, 2, and 3 were inoculated unilaterally into Stensen's duct with 0.4 ml. of active 
mumps virus of the 10th monkey passage diluted 1-20 in infusion broth. 
§ See footnote §, Table V. 
H  See footnote ¶,  Table V. 
¶ See footnote  [], Table V. 
** nd,  not  done. 
:~: ac,  serum was anticomplementary. 
tion in the evaluation of the clinical results.  Skin tests were performed before 
the fourth experiment on a  large group and only  those showing negative  tests 
were  selected  for  vaccination  (Table  VIII).  There  is  an  additional  reason, TABLE VII 
Group 3.  Results of Immunologic Studies 
Serial complement fixation  tests  Serial skin tests* 
Subgroup  Following  challenge 
2 
' 
9/14  ~  I  !  :4  10/20 10/27  1st  2nd  3d  4th  5th 
ill  o 
Received  2  0 
doses  of  0 
vaccine  0 
0 
0 
0 
0 
0 
0 
211  o 
Received  3  0 
doses  of  0 
vaccine  0 
0 
0 
0 
0 
0 
0 
31[  nd 
Controls re-  nd 
ceived no  nd 
vaccine  nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
>  nd 
1  nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
.nd 
nd 
? 
? 
nd 
0 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
Sen,' 
* First tests performed  8 to 16 days following tbe challenge.  Subsequent tests done at weekly  intervals there° 
afteruntilreactionsappearedorsensitivlty(denotedby"sens.")developed.  The fifth series of tests were done 
on November 15th. 
:~  All  dates  recorded  in  the  table  refer  to  the  year  1944. 
§ See footnote *, Table V. 
Subgroup I received  subcutaneously on September 14 and September 19,1944, 0.5 ml. of a pooled 2.5 per cent 
formolised susponsion of the in|ected parotid glands of tbe 12th and t4th monkey  passages.  Subgroup 2 received 
3 doses of the same material by the same route on September 14th, September 19th, and September 24th.  On 
September 29th the buccal mucosae of each individual in subgroups 1, 2, and 3 were sprayed with I ml. of pooled 
active virus of the 12th and 13th monkey passages diluted 1-25 in a medium consisting of I part infusion broth 
and 3 parts of physiologic  salt solution. 
¶ See footnote §, Table V. 
** ndj not done. 
~  See footnote ¶, Table V. 
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TABLE VIII 
Croup 4. Results of lmmunolog~ Studies 
Subgroup 
Received 
2  doses 
of  vac- 
cLUe 
2~ 
Controls 
received 
no  vac- 
cine 
35 
Possibly 
~mune 
by  com- 
plement 
fixation, 
or  skin 
test. No 
vaccine 
--I  Serial  skin  tests 
* See footnote  *, Table V. 
Subgroup I received subcutaneously on December 22nd and December 27th respectively 0.5 ml. of a 2.5 per 
cent formollzed infected parotid glared of the 15th monkey passage.  On January 5, 1945, the buccal mucosae of 
all the individuals in this subgroup as well as those in subgroups 2 and 3 were sprayed with l ml. of active Virus 
of the  14th  monkey passage diluted  1-15 in physiologic salt solution. 
§ See footnote § of Table V. 
H  ac, serum was anticomplementary. 
nd,  not done. 
** Serum fixed complement in presence of normal parotid suspension. 
:~ See footnote i[, Table V. 
§§ See footnote  ¶, Table V. 
then, to believe that the resistance which was demonstrated among the skin- 
negative vaccinated children in groups 3  and 4  was not due to previous in- 
apparent infection but to the inoculation of inactivated virus. STOKES~ EI~DERS,  MARIS  i  AND  ]LANE  423 
The Development of Complement-Fixing Antibody  Following Vaccination.~ 
Certain of the children in the first 3 experiments developed complement-fixing 
antibody after vaccination,  From Tables  V  and  VII,  it  is  apparent  that 
antibody formation was recognizable only following the second dose of vaccine. 
Furthermore, the results included in Table VII serve to define more exactly 
the time at which this antibody may be expected to emerge.  It was not present 
5 days but had appeared in some cases in moderate titer 10 days after the first 
dose of vaccine; i.e., at least 5 days before the challenge was administered. 
Although vaccination in  certain  individuals stimulated the  formation of 
antibody, it is obvious that not all those who were vaccinated so responded. 
Indeed this occurred in only 18 out of a total of 45, an incidence which was less 
than that recorded in analogous experiments in monkeys (1). 
Furthermore an increase in the amount of vaccine and the number of doses 
administered did not appear to increase the number of those who responded. 
This is evident from a comparison of the titers obtained after vaccination  an~t 
prior to challenge in the vaccinated subgroups of the third experiment (Table 
VII), in one of which 2 doses and in the other 3 doses were given of the same 
vaccine.  It is possible, however,  that had a longer l~riod intervened before 
challenge after the third dose had been given, antibody response would have 
been more frequent. 
Lack of Correlation between the Development after Vaccination o] Complement- 
Fixing Antibody and Resistance.--If the number in the vaccinated groups who 
developed antibody be compared with the number of those who were ~e0w 
sidered to be resistant or partially resistant as a  result of vaccination,i it:at 
once becomes evident that there is no constant association between the emer- 
gence of antibody and absence or modification of the disease.  Of 31 vaccinated 
individuals who were considered to be resistant, only 14 developed complement- 
fixing antibody.  The lack of constant relationship is particularly well shown 
by a comparison of the Clinical observations  and complement fixation  tests~in 
group 4 (Tables IV and VIII).  Only one case of moderately severe mumps was 
observed  among the  10 vaccinated children.  In spite of this high ~level:iof 
resistance,  no complement-fixing antibody was detected in any of these indi~ 
viduals prior to challenge.  Previously, results of ,vaccination experiments!in 
monkeys  likewise had failed to reveal a constant relationship between resistance 
and the presence of antibody at the time of challenge (1).  I~ these experimer~ts 
with human beings, on the other hand, it should be pointed out that with one 
possible  exception  (J.  S.,  group  1),  all those in whom antibody did appear 
subsequently provedrefractory on challenge:  Although its presence is usually 
associated with resistance, it would seem, :then, that demonstrable  complement- 
fixing antibody following vaccination is not an indispensable concomitant  ~  of 
immunity  either in the monkey or the human being.  A similar independence:of 
complement-fixing as well as of other antibodies and resistance has been:  shown 
in the case of other viral antigens (6, 7).  It should be clearly understood, how- 424  I~I~'NZTY  IN  ~a,s.  vx 
ever,  that these observations  do not in any way impair the significance of 
the presence  of complement-fixing antibody as an index of immunity when 
it occurs naturally in the serum. 
Appearance or Increase of Complement-Fixing Antibody Following Inoculation 
of Active Virus.--All  the  controls  originally regarded  as  being  susceptible 
developed antibody following the challenge with active virus.  This response 
suggests  strongly, particularly in the case of those who were inoculated by 
spraying, that infection had taken place in every control, whether or not there 
were accompanying symptoms.  But the appearance of antibody under these 
conditions cannot be accepted as absolute evidence for infection, at least when 
the virus is introduced directly into the parotid, as will be presently pointed out. 
The approximate time after challenge at which antibody first appeared in 
the controls can be determined from the data presented in Tables V, VI, VII, 
and VIII.  Following the intraparotid inoculations in groups 1 and 2, antibody 
could not be demonstrated in the sera of the controls on the 7th day but was 
present in nearly all instances by the 14th day.  In contrast, after inoculation 
by spray antibody could not be revealed on the 14th day but was demonstrable 
on the 21st day.  These findings are consistent with the difference in incubation 
times following the two routes of inoculation. 
In most instances the maximal titers were in the range usually encountered 
in convalescence from the natural disease.  On the whole, however, the highest 
levels reached in the controls of groups 3 and 4 were lower than those observed 
in the controls of groups 1 and 2.  Possibly the direct inoculation of the parotid 
gland may tend to give rise to a more pronounced antigenic stimulation. 
Fourfold or greater increases in the titers were also noted in the group of 3 
individuals who  had naturally occurring  antibody in  their blood  and were 
challenged via Stensen's duct (Table VI).  It is impossible to determine whether 
this phenomenon depended on a response to the establishment of an inapparent 
infection or whether the active virus introduced into the gland without causing 
infection acted merely as an antigen, not endowed with the capacity of multi- 
plication, to stimulate a rise in the level of circulating antibody.  Considerable 
support for the latter hypothesis is to be found in the results of unpublished 
experiments in which it has been shown that formol-inactivated virus intro- 
duced into the parotid gland of normal monkeys was antigenic.  Because of 
the foregoing considerations, it is impossible to state categorically  that antibody 
response  following  intraparotid  challenge  is  alone  conclusive  evidence  of 
infection. 
With the serologic behavior of the non-vaccinated, we may compare the 
results following the challenge in the vaccinated groups.  In 27 children who 
failed to develop  antibody as a  result of vaccination, it appeared after the 
active virus had been administered.  In such children--at least in those who 
received  the virus as a spray--the agent presumably entered the tissues and STOKES, .ENDERS~ ]~ARIS, AND KANE  425 
gave rise to an infection.  Whether or not overt disease ensued, this infection' 
would almost certainly lead to permanent immunity.  In this connection it 
will be recalled that for the immunization of dogs against distemper, Laidlaw 
and Dunkin (8) employed a procedure whereby the incomplete and transitory 
immunity induced  by formol-inactivated virus  was  reinforced  by  the  sub- 
sequent inoculation of active material. 
Quite otherwise were the results in those who did develop antibody in re- 
sponse to vaccination.  Only 4 of a  total of 18 yielded evidence of further 
increase in titer after challenge.  In none of those who had developed antibody 
and  who  were  inoculated by  spraying  (Table  VII)  did  the  antibody sub- 
sequently  increase  in  concentration.  Such  behavior  might  be  interpreted 
unequivocally as indicative of complete immunity were it not for the fact that 
the antibody persisted for a long time as will be immediately pointed out. 
The Persistence  of Antibody after ChaUenge.--About 13 months after challenge, 
complement fixation tests were done on specimens of serum from 31  of the 32 
individuals who were originally included in groups 1 and 2 (Tables V and VI). 
At that time antibody was found in the sera of 30 children.  One child (A. R., 
Table V) gave a doubtful test.  The antibody levels had declined in all sa,ce 
3  instances to those characteristic  of persons  who have undergone natural 
attacks of mumps at some time in the more or less remote past (2, 3).  The 
3 exceptions (F. O. and G. DiC., Table VI,  and  A. R., Table V)  exhibited 
titers slightly above the highest normal level (1-96)  usually encountered (3). 
The persistence of antibody in the vaccinated as well as in the controls strongly 
suggests that the former had experienced an infection as a result of the challenge 
whether or not symptoms or increase in antibody titer upon challenge had been 
observed, since it is unlikely that antibody induced as a result of vaccination 
with inactive virus would endure so long. 
The Development of Dermal Hypersensitivity Following Challenge.--In groups 
1 and 2 skin tests were first carried out about 14 months after challenge (Tables 
V and VI).  Among the 31  children included in these experiments, 17  were 
definitely positive and 6 were doubtful, 3 were negative, 2 reacted to normal 
monkey protein, and 3 were no longer available for test.  Because skin tests 
were not done at the outset] it is impossible to be certain of the exact number 
who became sensitive as a  result of the experimental procedures.  However, 
on the basis of the correlation which has been shown to exist between the results 
of the skin and complement fixation test in normal individuals (4), it is probable 
that a large proportion of the children who originally were negative by comple- 
ment  fixation test were also skin-test-negative at the outset and so became 
hyperserisitive to the virus or its products following the challenge. 
The third experiment (Table VII) in general yielded more data of the  same 
sort,  although the  incidence of those who developed definitely positive skin 
tests after the challenge was lower.  Tests  on 30 children done 8 to 16 days 426:  IM2~UNITY : IN  M'UM.PS.  VI 
after challenge were definitely positive in 4 and so are to be interpreted in these 
cases as probable  indications  of previous  exposure  to the virus.  The results 
of subsequent tests performed at weekly intervals during the following month 
showed that 6 of those who were negative or doubtful by the first test became 
positive  and  10  others  originally negative  became  doubtful.  Sensitivity  to 
monkey protein in 3 children made it impossible to determine whether specific 
hypersensitivity  was present.  One individual  showed no evidence  whatever 
of becoming sensitive to the virus dUring the period of study.  Many of those 
in group 4 also failed to become skin-positive.  Inspection of Table VIII will 
show that only 7 of a total of 25 individuals became definitely positive and only 
3 doubtful within 2 months after the challenge. 
We are unable to give an entirely satisfactory explanation for the failure of 
so many individuals  in  the  third  and fourth experiments  to become frankly 
hypersensitive  within  the  periods  of  observation.  But  it  is  probable  that 
certain  of those who had not developed hypersensitivity would have done so 
at a  later date, since it has been shown  that  in some persons hypersensitivity 
is established  only after  the lapse  of 2 months  following the  onset  of symp- 
toms  (2). 
The  Possibility of  Increased  Resistance  as  a  Result  of Skin  Testing.--A 
correlation  of the  immunologic  behavior  of the  5  children  in  subgroup  3  of 
group 4 (Table VIII) with the clinical observations is instructive. 
It is evident that 4 of the ctiiJdren, in contrast to those in subgroups 1 and 2 responded to 
the intradermal  test by the development of complement-fixing antibody,  although  none of 
them originally exhibited definitely positive skin reactions.  To test the significance of this 
antibody response in relation to resistance, vaccination with formolized material was omitted. 
Following the challenge, 3 of them failed to show any increase in antibody titer and did not 
develop skin sensitivity during the period of observation.  In contrast, the fourth child (T. P.), 
who exhibited only a low titer of antibody after the skin test, responded after the challenge by 
producing antibody in considerable amount and presented  a doubtful  indication  of dermal 
hypersensitivity.  Of these 4 children he was the only one who developed unmistakable signs 
of mumps.  The fifth child in this subgroup (J. T.) showed a skin reaction to the first test at 
24 hours which disappeared by 48 hours; but antibody did not appear in his serum as a result 
of skin testing.  This boy did not present signs of mumps following challenge nor on subse- 
quent skin tests was any dermal reaction elicited.  Nevertheless antibody emerged in moder- 
ate titer which suggests that infection had occurred in an inapparent form. 
These findings afford additional evidence to show that in certain skin-test- 
negative individuals, most of whom presumably have not had previous contact 
with  the virus,  the  intradermal  inoculation  of virus  heated  at  65°C.  for 20 
minutes  may  occasionally  induce  the  fornmtion  of  antibody;  i.e.,  act  as  a 
primary  antigenic  stimulus  (4).  They  suggest,  moreover,  that  increased 
resistance may on occasion also follow such intradermal  inoculations whether 
or not antibody is evident and so afford some support for the hypothesis already 
presented  to account  for  the  failure  of a  relatively  large  proportion  of the STOKES,  ENDERS,  MARIS,  AND  KANE  :42 7 
controls in group 4 to develop overt disease.  That resistance is not invariably 
increased  by skin testing, however,  is shown by the  development of mumps 
in patient T. P. 
COMMENT 
It remains here to consider how much the results which have already been 
critically analyzed contribute to the problem of the development of a practical 
method for the induction of active artificial immunity against mumps. 
Vaccination  with  formol-inactivated virus  apparently  led  to  increased 
resistance in about 50 per cent of the children in each of 4 groups whose immuno- 
logic status was subsequently tested by experimental inoculation of pathogenic 
material.  This degree of protection in human beings is of the same magnitude 
as that observed in monkeys vaccinated in the same manner (1).  Evidently, 
then, the vaccine as employed in these experiments did not induce that level of 
immunity which  would be desirable  from the ideal standpoint.  Moreover, 
when administered to persons who had previously been exposed in the ordinary 
manner to mumps, it failed to prevent parotitis. 
Notwithstanding these limitations, we are inclined to regard the findings as 
definitely encouraging  because  of the following considerations.  It has been 
shown that it is possible to achieve in man an immune response by the paren- 
teral inoculation of inactivated virus,  That this could be done at all might have 
been seriously doubted because Johnson and Goodpasture failed to demonstrate 
in monkeys increased resistance  following the injection of active virus by any 
route other than the parotid duct or the oral cavity (5).  Furthermore, the 
protective effect of the vaccine  might be apparent in a  larger proportion of 
persons under conditions of less severe subsequent  exposure.  Thus it would 
seem probable that the amount of virus used for challenge in 'our experiments 
was much greater than that which usually would be received through natural 
contact with the disease.  The experimental conditions were also exacting in 
that a fairly short period of 10 to 12 days or less was allowed to elapse betweeii 
the last dose of vaccine and the application of the challenge.  It is true that 
in certain individuals this was sufficient to provide for the development of 
complement-fixing  antibody.  Nevertheless  it  may have  been  too  brief  to 
permit the factors of resistance--whatever these may be--to attain in every 
person complete mobilization.  It is scarcely necessary to point out here that 
the maximal effect of vaccination against tetanus, diphtheria, and pertussis 
cannot be expected within the interval we have employed. 
The results of serial complement fixation tests indicated that in many of the 
individuals who showed no definite signs of mumps vaccination did not entirely 
prevent infection since antibody appeared in their blood after the  challenge 
inoculation.  This further  evidence  against the  capacity of the  vaccine  to 
induce complete immunity need not necessarily be interpreted in a  pejorative 428  IMMUNITY  IN  MUMPS,  VI 
sense.  Indeed, these observations suggest that the vaccine could be employed 
to provide a partial immunity which in turn might permit inapparent or much 
modified infection to occur upon subsequent natural exposure to  the virus-- 
an event which would be expected to induce a solid and enduring immunity. 
Furthermore, vaccination with formolized material might prove  of value in 
reducing the incidence of complications such as orchitis or  encephalitis.  In 
the experiments which have been described, each of these conditions has been 
occasionally" observed.  None  of  these  patients  had  been  vaccinated.  No 
conclusion, however, in this respect can be drawn on the basis of the available 
data. 
CONCLUSION 
The results observed after experimental  inoculation of active  mumps virus 
into 41 vaccinated and 32 unvaccinated children,--with the consent of their 
parents  or guardians,--indicated that formol-inactivated mumps virus ob- 
tained from  the parotid gland  of the infected  monkey  and employed  as a vaccine 
in the manner which has been described  increased  the resistance  of about half 
of those to whom it was administered. 
BIBLIOGRAPHY 
!" Enders, J. F., Kane, L. W., Cohen, S., and Levens, J. H., J. Exp. Med., 1945, 81, 
93. 
2.  Endcrs, J. F., Cohen, S., and Kane, L. W., J. Exp. Med., 1945, 81, 119. 
3.  MarLs, E. P., Enders, J. F., Stokes, J., Jr., and Kane, L. W., J. Exp. Med., 84, 323. 
4,  Enders, J. F., Kane, L. W., Maris, E. P., and Stokes, J., Jr., J. Exp. Meal., 84, 341. 
5.  Johnson, C. D., and Goodpasture, E. W., Am. J. Hyg., 1936, 23, 329. 
6.  Parker, R. F., J. Exp. Mcd., 1938, 67, 361. 
7.  Rivers, T. M.~ Lane Medical Lectures: Viruses and Virus Diseases, Stanford Uni- 
versity Publica.tions, University Series, Medical  Sciences, 4, No.  i, Stanford 
University Press, 1939, 68. 
8. Laidlaw, P. P., and Dunkin, G. W., J. Comp. Path. and Thcrap., 1928, 41,209. 